Bradley Anawalt, MD
Dr. Anawalt is the Chief of Medicine at the University of Washington Medical Center and Professor and Vice Chair of the Department of Medicine at the University of Washington. His principal areas of research are in male infertility, male hormonal contraception and male reproductive physiology. His excellence in teaching has been recognized with several University of Washington Department of Medicine teaching awards: 2014 Marvin Turck Award for excellence in teaching and clinical care, 2007 Endocrinology Fellowship Teaching Award, and 1999 Paul Beeson Award (selected by the internal medicine residents). He has been the North American editor for the Journal of Clinical Endocrinology (2012-2020), Associate Editor for Endocrine Reviews (2014-2017) and has served on the editorial board of the Journal of Clinical Endocrinology and Metabolism (2006-2010 and 2010-2014). He has won outstanding reviewer awards from the Journal of Clinical Endocrinology and Metabolism and the Annals of Internal Medicine. He serves as a consultant to the United States Anti-Doping Agency. He has had leadership positions in the United States Endocrine Society including Council member (2014-2017), Chair of the Hormone Health Network (2006-2010 and 2010-2014) and Clinical Chair of the 2011 Annual Meeting. His clinical focus is in the area of male reproductive endocrinology, and he has received several national and regional awards from his peers for clinical expertise. He earned his bachelor’s degree in anthropology at the University of Santa Clara and his medical degree at the University of California at Davis. He completed his internal medicine residency at the University of Washington in 1992 and served as chief resident at the Seattle VA Medical Center 1992-1993. He completed a fellowship in endocrinology at the University of Washington and joined the faculty in 1995.
Alison Boyce, MD
Alison Boyce, MD is a pediatric endocrinologist and Associate Research Physician in the Skeletal Diseases and Mineral Homeostasis Section, National Institute of Dental and Craniofacial Research, National Institutes of Health. Dr Boyce’s work focuses on bone and mineral metabolism, including rare and pediatric skeletal disorders. She is the Principal Investigator of a natural history study in fibrous dysplasia/McCune-Albright syndrome, a rare disease affecting the skeletal and endocrine systems, and has characterized many aspects of this disorder and its treatment. Additional studies focus on disorders of fibroblast growth factor-23, primary connective tissue disorders, and hypoparathyroidism. Dr Boyce is a faculty member in the joint National Institutes of Health and Children’s National Pediatric Endocrinology fellowship training program. She holds an adjunct position at Children’s National Health System, where she attends in the multidisciplinary Bone Health clinic in partnership with the Division of Orthopaedics. She is a founding member of the Fibrous Dysplasia/McCune-Albright Syndrome International Consortium, and serves as Medical Advisor to the Fibrous Dysplasia Foundation.
George Chrousos, MD, MACE, MACP, FRCP(UK)
Professor of Pediatrics and Endocrinology, Division of Endocrinology, Metabolism and Diabetes, First Department of Pediatrics, National and Kapodistrian University of Athens Medical School, "Aghia Sophia" Children's Hospital, Athens, Greece. Division of Endocrinology and Metabolism, Biomedical Research Foundation of the Academy of Athens, Athens, Greece. E-mail: email@example.com; firstname.lastname@example.org; email@example.com
Ketan Dhatariya, MBBS, MSc, MD, MS, FRCP, PhD
Professor Ketan Dhatariya graduated from the University of London in 1991 and did his diabetes and endocrinology training in and around London. For 2 years during his training he was also a part time General Practitioner in the evenings. He took some time out of his training to spend a year doing intensive care medicine and anaesthetics. After he finished his diabetes training in 2001 he went to do a 2 year research fellowship in endocrinology at Mayo Clinic in Minnesota, USA. He was appointed as a consultant in diabetes, endocrinology and general medicine at the Norfolk & Norwich University Hospital in 2004, and Honorary Professor of Medicine at the University of East Anglia in 2019.
He is a full time clinician and his predominant areas of interest are inpatient diabetes – in particular peri-operative diabetes care, the management of diabetes related emergencies, and the ‘diabetic foot’. He leads one of the largest foot clinics in the East of England.
He has several national roles in the UK. He is currently the Chair of the Joint British Diabetes Societies Inpatient Care Group where he has led or co-authored several national guidelines on the management of various aspects of inpatient diabetes care including the guideline on peri-operative diabetes care. He is the Chair of the Examining Board for the UK Specialist Clinical Exam in Diabetes and Endocrinology, as well as Chair of the newly developed European Board Examination in Endocrinology, Diabetes and Metabolism. He is the President of the Diabetes and Endocrine section of the Royal Society of Medicine. He is an Associate Editor of Diabetic Medicine and BMJ Open Diabetes Research & Care.
Dr Dhatariya has over 140 peer reviewed publications, and has published over a dozen book chapters on inpatient diabetes, peri-operative diabetes care or on the diabetic foot.
You can find more by visiting www.norfolkdiabetes.com
Kathleen Dungan, MD, MPH
Associate Professor of Medicine at The Ohio State University Division of Endocrinology, Diabetes and Metabolism. Dr. Dungan attended medical school at OSU and completed her residency and fellowship in 2006 at University of North Carolina. She then returned to OSU where she serves as the division Associate Director of Clinical Services and the director of endocrine clinical trials, and oversees the inpatient diabetes program. She divides her time in clinical care and research in diabetes. Her research focuses on diabetes clinical trials, and ranges from quality improvement, pharmaceutical, and device interventions in the inpatient and outpatient settings. She has presented several times at national meetings such as the ADA and Endocrine Society and has published numerous manuscripts and chapters ranging from glucose monitoring, incretin based therapies, and insulins, to mechanistic and outcomes studies in hospitalized patients. She serves on the editorial board of Diabetes Technology & Therapeutics. She serves as the American Diabetes Association Central Ohio Community Leadership Board president and on the national ADA Scientific Sessions planning committee.
Kenneth R. Feingold, MD
Kenneth R. Feingold, MD, received his medical degree from the State University of New York, Upstate Medical Center in Syracuse, New York. He completed his internship and residency in internal medicine at the University of Wisconsin in Madison, Wisconsin and a fellowship in endocrinology and metabolism at the University of California, San Francisco. He is currently an Emeritus Professor of Medicine in the Endocrinology Section at the University of California San Francisco. For many years he was Chief of the Endocrine Clinic at the San Francisco VA.
Dr. Feingold is a member of the American Society for Clinical Investigation, American Diabetes Association, and Endocrine Society. He is an associate editor for the Journal of Lipid Research. He has served on NIH study sections and the V.A. Merit Review Board for Endocrinology.
Dr. Feingold’s clinical interests have focused on diabetes, obesity, and lipid disorders. His laboratory has studied the effects of inflammation on lipid and lipoprotein metabolism, the role of lipid synthesis and metabolism in the epidermis in forming the cutaneous permeability barrier, and the role of oxidized lipids in inducing atherosclerosis.
Ashley Grossman, BA, BSc, MD, PhD (Hon. Causa), FRCP, FMedSci
Professor of Endocrinology, Barts and the London School of Medicine, London, and Green Templeton College, University of Oxford, UK. firstname.lastname@example.org
Jerome Hershman, MD
Jerome M. Hershman, MD, MS, MACP is Distinguished Professor of Medicine at the David Geffen School of Medicine at UCLA, Associate Chief of the Endocrinology and Diabetes Division at the West Los Angeles VA Medical Center and Director of its Endocrine Clinic.
He was the Editor of the journal Thyroid from 1991-2000. He received a B.S. in chemistry from Northwestern University, a M.S. in chemistry from the California Institute of Technology, and a M.D. from the University of Illinois School of Medicine in Chicago. He was a resident in internal medicine at Beth Israel Hospital in Boston and the Boston VA Hospital and trained in endocrinology at the New England Medical Center. Dr. Hershman was a faculty member in the Department of Medicine at Northwestern University for 3 years, then at the University of Alabama in Birmingham for 5 years before moving to UCLA in 1972. He has authored over 340 research papers in endocrine literature and written more than 100 authoritative book chapters and reviews about thyroid function and disease. His current research focuses on the molecular biology of thyroid cancer and the management of thyroid diseases.
Hans Hofland, MD
Hans (J.) Hofland MD PhD is a Consultant Endocrinologist and Clinician Scientist at the Erasmus MC and Erasmus MC Cancer Center, Rotterdam, the Netherlands. He is specialized in the fields of steroid biology, endocrine oncology and radionuclide therapy.
Gregory Kaltsas, MD, PHD, FRCP
Professor of Internal Medicine Endocrinology, 1st Propedeutic Department of Internal Medicine, National and Kapodistrian University of Athens 115 27, Greece. email@example.com
Christian A. Koch, MD, PhD, FACP, MACE
Prof. Koch is presently the Head of the Medicover MVZ Oldenburg and affiliated with the Carl von Ossietzky University as well as theTechnical University of Dresden. He also is Adjunct Professor at the University of Louisville, KY. Before June 2017, Koch had served as a tenured professor at the University of Mississippi Medical Center in Jackson, MS,
and Staff Physician at the G.V. (Sonny) Montgomery VA Medical Center. Prof. Koch’s focus has been the pathogenesis of endocrine tumors and endocrine hypertension.
Peter Kopp, MD
Peter Kopp is a Professor of Medicine and Médecin Chef in the Division of Endocrinology, Diabetology and Metabolism at the University of Lausanne, Switzerland. Dr. Kopp obtained his MD degree and his training in Internal Medicine and Endocrinology at the University of Berne, Switzerland. In 1993, he moved to the United States for a research fellowship supported by a grant of the Swiss National Science Foundation and joined Dr. Larry Jameson at Northwestern University in Chicago. After 3 years, he joined the faculty at Northwestern and rose through the ranks to full professor. He has directed the Center for Genetic Medicine (CGM) at the Feinberg School of Medicine of Northwestern University in Chicago from 2007 to 2014. In 2018, he has moved back to Switzerland to his current position.
Dr. Kopp has extensive clinical experience in clinical endocrinology with a focus on thyroid cancer and thyroid dysfunction. His research is focusing on the molecular pathophysiology and genetics of thyroid and other endocrine disorders. Since 2013 he is the Editor-in-Chief of the journal Thyroid, an appointment that reflects his recognized expertise in clinical and basic thyroidology. He has been a member of the thyroid cancer guideline panel of the National Comprehensive Cancer Network from 2002 to 2018. Dr. Kopp is an author or co-author of more than 170 publications, including chapters in major textbooks such as Harrison's Principles of Internal Medicine and he serves as a co-editor of Werner and Ingbar’s textbook The Thyroid.
Márta Korbonits, MD, PhD, DSc, FRCP
Márta Korbonits, MD, PhD, DSc, FRCP is Professor of Endocrinology and Metabolism, Centre Lead for Endocrinology and Deputy Institute Director at William Harvey Research Institute at Barts and the London School of Medicine and Dentistry, Queen Mary University of London. She is a graduate from the Semmelweis Medical School, Budapest. She was a Medical Research Council Clinician Scientist Fellow working on ghrelin and the hormonal regulation of the metabolic enzyme AMP-activated protein kinase. Her current interests include endocrine tumorigenesis, especially the genetic origin of pituitary adenomas and other endocrine tumour syndromes. She works on both the clinical characterisation as well as molecular aspects of pituitary diseases and leads a large international consortium to study these rare conditions. She published over 200 original papers and has a Scopus H-index of 53. She shares her time between clinical patient care, clinical research and laboratory based research as well as teaching at undergraduate and postgraduate level. She was a recipient of the Society for Endocrinology Medal, the Endocrine Society Delbert Fischer award, The Harrison Award from the Endocrine Society of Australia, The Hadden Lecture Award from the Irish Endocrine Society and the Lady Estelle Wolfson Lecture Award. She was member of the executive board of the Society for Endocrinology, Pituitary Society, European Neuroendocrine Association and European Society of Clinical Investigation. She is Programme Committee Chair for the European Society of Endocrinology. As an Associate Editor for the Journal of the Endocrine Society and for ENDOTEXT she is responsible for the pituitary field. She is member of editorial board of Scientific Reports, Annals of Human Genetics, Journal of Clinical Endocrinology and Metabolism, and Pituitary.
Christopher S. Kovacs, MD, FRCPC, FACP, FACE
Dr. Christopher S. Kovacs is University Research Professor, and Professor of Medicine (Endocrinology and Metabolism), Obstetrics & Gynecology, and BioMedical Sciences, at Memorial University of Newfoundland in St. John’s, Newfoundland, Canada.
He obtained his MD and did an Internal Medicine residency at Queen’s University, an Endocrinology fellowship at University of Alberta, a postdoctoral research fellowship in bone and mineral metabolism at Harvard Medical School and Massachusetts General Hospital, and training in bone histomorphometry at University of Melbourne.
His practice involves osteoporosis and general endocrinology. His research focuses on bone and mineral metabolism during pregnancy, lactation, and fetal development.
Among more than a dozen awards for research accomplishments, he received the Gold Medal in Medicine from the Royal College of Physicians and Surgeons of Canada, the Dr. Harvey Guyda Educator of the Year Award from the Canadian Society of Endocrinology and Metabolism (CSEM), and Young Investigator Awards from the American Society for Bone and Mineral Research, Advances in Mineral Metabolism, and CSEM. He has served on the Institute of Medicine of the National Academies of Science, study sections of the National Institutes of Health, and Canadian Institutes of Health Research panels. He has been a consultant to the Centers for Disease Control and Prevention in Atlanta, Canadian Agency for Drugs and Technologies in Health, and Health Canada. He conceived and edited the multi-authored textbook Maternal-Fetal and Neonatal Endocrinology: Physiology, Pathophysiology, and Clinical Management (Elsevier, 2019).
Wendy Kuohung, MD
Dr. Wendy Kuohung is the Director of the Division of Reproductive Endocrinology at Boston Medical Center and an Associate Professor of Obstetrics and Gynecology at the Boston University School of Medicine. Dr. Kuohung received her medical degree from the Yale University School of Medicine. She completed her residency in Obstetrics and Gynecology at Boston University Medical Center and fellowship training in Reproductive Endocrinology and Infertility at Brigham and Women’s Hospital, Harvard Medical School. Dr. Kuohung is a former Reproductive Scientist Development Program scholar and has received several NIH research grants since 2003. She received the BUSM Resident Award for Excellence in Teaching in Ob/Gyn in 2001 and the Harvard Medical School Teaching Award in Reproductive Endocrinology in 2003. She has published numerous peer-reviewed publications and chapters. Her research interests lie in infections of the placenta and reproductive tract, and she has clinical expertise in advanced minimally invasive gynecologic surgery, female infertility, and fertility preservation. In addition to Boston University Medical Center, her practice sites include Boston IVF in Waltham, MA, USA.
Blandine Laferrère, MD, PhD
Dr. Blandine Laferrère is Professor of Medicine at Columbia University, a full time Attending Physician in the Division of Endocrinology, and board certified in endocrinology. She got her medical degree from the University Claude Bernard in Lyon, France, where she did her residency and trained as an endocrinologist. During a post-doctoral fellowship in the laboratory of Dr. Richard Wurtman, at Massachusetts Institute of Technology, she studied neuropeptide regulators of food intake behavior. Later in the laboratory of Dr. Harry Kissileff at the New York Obesity Research Center, she studied laboratory measures of food intake behavior in humans. She has dedicated her research carrier on the endocrine aspects of obesity and type 2 diabetes, first on the regulation of leptin and ghrelin under the mentorship of Dr. Xavier Pi-Sunyer, then more recently on the role of the incretin hormones as possible mechanism of glucose control after bariatric surgery. Dr. Laferrère is the Director of the Translational Biomarker Core of the Columbia Diabetes Research Center. In July 2019, she became the Columbia site PI for two landmark studies, the DPPOS and the LookAHEAD study. She is a visiting Professor in the laboratory of Dr. François Pattou in Lille, France.
Elizabeth A. McGee, MD
Elizabeth McGee MD received her medical degree from the University Of Tennessee College Of Medicine in Memphis. Her residency in obstetrics and gynecology and a fellowship in reproductive endocrinology and infertility were completed at the University of Texas, Southwestern/ Parkland Memorial Hospital in Dallas. She also completed a research fellowship as a Reproductive Scientist Development Program Scholar at Stanford University with Aaron Hsueh. She is currently a Professor of Obstetrics and Gynecology at the University of Vermont and Director of the Division of Reproductive Endocrinology and Infertility and the UVM Center for Reproduction.
Dr McGee is a member of ASRM, SREI, SSR, SRI, and Endocrine Society. She has served on NIH study sections, and programmatic reviews, and is a board examiner for the American Board of Obstetrics and Gynecology. She has been on the editorial boards of Reproduction, Biology of Reproduction and Clinical and Experimental Reproductive Medicine, and is an associate editor of Journal of Assisted Reproduction.
Her clinical interests are infertility, endocrinology and menopause. Her research has focused on ovarian physiology and folliculogenesis, hormone function, TGFb, access to care and interdisciplinary women’s health.
Robert McLachlan, MD, PhD
Professor Robert McLachlan is Director of Clinical Research at the Hudson Institute of Medical Research and Consultant Endocrinologist at the Monash Medical Centre in Melbourne, Australia. He is a physician-scientist having obtained a PhD in reproductive medicine from Monash University in 1987 and then he undertook a position as a Visiting Scientist at the University of Washington, Seattle with Dr William Bremner in 1987-1989. Upon returning to Australia he has developed clinical and research interests in the fields of spermatogenesis, male fertility regulation and androgen physiology. He is Consultant Andrologist to the Monash IVF Group with research interests in the genetics of male infertility. He has served as President of the Fertility Society of Australia and as Secretary of the International Society of Andrology, and as a consultant to the WHO on male fertility regulation. Since 2006, he has been Director of the Andrology Australia, a Federal Government initiative committed to research and community & professional education in male reproductive health. He has published more than 220 original papers, reviews and chapters and serves on editorial boards of leading endocrine and andrology journals, and as Editor of the Male Reproduction Section of www.ENDOTEXT.org .
John Morley, MB, BCh
John E. Morley, MB, BCh, is the Dammert Professor of Gerontology and Director of the Division of Geriatric Medicine and the Director of the Division of Endocrinology at Saint Louis University Medical Center. He also serves as Medical Director for two nursing homes.
Dr Morley earned a medical degree at the University of Witwatersrand, in Johannesburg, South Africa. After an internal medicine residency in Johannesburg, he completed a fellowship in endocrinology at the University of California, Los Angeles.
He has edited more than 20 books, and published more than 1300 papers, with major research emphases on the role of neuropeptides in the modulation of hormonal responses and behavior and on nutrition, geriatric assessments, diabetes and hormones in the elderly. He serves as Editor of Journal of the American Medical Directors Association.
Maria New, MD
Adrenal Steroid Disorders Group. Department of Pediatrics. Mount Sinai School of Medicine. New York, NY. firstname.lastname@example.org
Jonathan Q. Purnell, MD
Dr. Jonathan Q Purnell is a Professor of Medicine in the Oregon Health & Science University Knight Cardiovascular Institute and the Division of Endocrinology, and is the Associate Director of the Bob and Charlee Moore Institute for Nutrition and Wellness. He completed medical school at Oregon Health & Science University, Internal Medicine residency at the University of Vermont, and Endocrine Fellowship at the University of Washington under the mentorship of Dr. John Brunzell. His work as a physician scientist focuses on understanding the causes and consequences of obesity, metabolic syndrome, dyslipidemia, and diabetes in humans. Dr. Purnell is a member of the American Physiology Society, The Endocrine Society, The Obesity Society, The American Federation of Medical Research, and The American Diabetes Association.
Frederick Singer, MD
Director, Endocrine/Bone Disease Program, John Wayne Cancer Institute, 2200 Santa Monica Blvd, Santa Monica, CA 90404. Clinical Professor of Medicine, UCLA. email@example.com
Constantine A. Stratakis, MD, D(med)Sci, PhD(hc)
Constantine A. Stratakis is recognized for his research, mentorship, and leadership and he remains an active clinician seeing patients with endocrine and genetic disorders. Over the last 25 years in his research, Dr. Stratakis has employed genome-wide tools to identify most of the genes known to predispose to adrenocortical tumor (ACT) and pituitary adenoma (PA) formation. His laboratory has identified the genetic defects for Carney complex, Carney Triad, the dyad of paragangliomas and gastric stromal sarcomas (a.k.a. Carney-Stratakis syndrome), and described new entities such as X-LAG (X-linked acrogigantism) and 3-PAs (the 3 Ps association of paragangliomas pheochromocytomas and PA). It was his identification of the protein kinase A (PKA) regulatory subunit type 1A (PRKAR1A) as the gene responsible for Carney complex in 2000 that led to the identification of the PRKACA gene as the most commonly mutated gene in all benign ACTs in 2014. Dr. Stratakis described novel genes, such as GPR101 in gigantism, and succinate dehydrogenase (SDH) defects in a variety of tumors, and led the efforts to show that many gastric stromal sarcomas (GIST) form due to SDH deficiency. He is the author of more than 700 publications, his work has been cited >25,000 times, and he served in major Editorial roles, including Deputy Editor, Journal of Clinical Endocrinology and Metabolism (2010-2015) and co-Editor, Hormone & Metabolic Research and Molecular & Cellular Endocrinology (2016/7-today). Dr. Stratakis received the 1999 Award for Excellence in Published Clinical Research and the 2009 Ernst Oppenheimer Award, both from the Endocrine Society, and the 2019 Dale Medal from the Society for Endocrinology and many other honors. He also has been named Visiting Professor in academic centers around the world and has received two honorary degrees from the Universities of Liege and Athens, respectively. As a mentor, Dr. Stratakis has trained more than 200 students, residents, pre-doctoral, post-doctoral and clinical fellows, and now nurtures the careers of junior faculty members and investigators. He has received numerous recognitions for his mentorship and teaching. Dr. Stratakis is widely recognized for his leadership, including in professional organizations. He just completed his year as the 2018-2019 President of the Society for Pediatric Research (SPR), and served as Scientific Director, NICHD, NIH (2009-20).
Dace Trence, MD
Dace L. Trence, MD, FACE is currently Director of the Diabetes Care Center and Associate Professor of Medicine at the University of Washington Medical Center in Seattle. She is also the University of Washington Endocrine Fellowship Program Director and Director of Endocrine Days, a medical education program for endocrinologists practicing in the Pacific Northwest. She currently serves on the American Association of Clinical Endocrinologists Board of Directors, chairing the AACE CME committee. She has been on the editorial boards of several journals including Clinical Diabetes. She has had articles published in JCEM, JAMA, Diabetes Care and is a co-author of Optimizing Diabetes Care for the Practitioner. Her current interests include improving educational processes in diabetes self management, clinical training of health care professionals, and vitamin D effects on glycemic control.
Don P. Wilson, MD, FNLA
Diplomate, American Board of Clinical Lipidology, Endowed Chair, Pediatric Cardiovascular Health and Risk Prevention, Pediatric Endocrinology and Diabetes. Cook Children’s Medical Center, Fort Worth, Texas. firstname.lastname@example.org
Wouter W. de Herder, MD
Wouter W. de Herder MD PhD is Professor of Endocrine Oncology at the Erasmus MC and Erasmus MC Cancer Center, Rotterdam, the Netherlands.